Company Description
Starpharma Holdings (OTC Link: SPHRY) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $37.2M.
SPHRY has gained 617.2% over the past year. Shares last traded at $4.69.
This page collects what Stock Titan holds for SPHRY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Starpharma Holdings (SPHRY) stock last closed at $4.69. Over the past 12 months, the stock has gained 617.2%. At a market capitalization of $37.2M, SPHRY is classified as a micro-cap stock with approximately 41.8M shares outstanding.
Latest News
Starpharma Holdings has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all SPHRY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Starpharma Holdings (SPHRY) currently stands at 1 shares, a new position with no short interest reported in the previous period. Since August 2025, short interest has decreased by 99.5%.
Days to Cover History
Days to cover for Starpharma Holdings (SPHRY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SPHRY Company Profile & Sector Positioning
Starpharma Holdings (SPHRY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SPHRY often look at related companies in the same sector, including POOLBEG PHARMA PLC (POLBF), Sernova Biotherapeutics Inc (SEOVF), Relief Hldg (RLFTF), MindMaze Therapeutics Holding SA (RLFTY), and Covalon Technologies Ltd (CVALF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SPHRY's relative position within its industry.